EFFICACY AND SAFETY OF DEOXYARBUTIN 307 (6) K. B. Penney, C. J. Smith, and J.C. Allen, Depigmencing action of hydroquinone depends on dis­ ruption of fundamental cell processes,]. Invest. Dermatol., 82, 308-310 (1984). (7) A. Palumbo, M. D'ischia, G. Misuraca, and G. Prata, Skin depigmentation by hydroquinone: A chemical and biochemical insight, Pigment Cell Res., 2 (Suppl.), 299-303 (1992). (8) E. Serra-Baldrich, M. J. Trib6, and J. G. Camarasa, Allergic contact dermatitis from kojic acid, Contact Dermatitis, 39, 86 (1998). (9) M. Nakagawa, K. Kawai, and K. Kawai, Contact allergy to kojic acid in skin care products, Contact Dermatitis, 32, 9-13 (1995). (10) L. Petit and G. E. Pierard, Skin-lightening products revisited, Int.]. Cosmet. Sci., 25, 169-181 (2003). (11) Y. Hirn, S. Hatae, T. Inoue, and Y. Ohyama, Inhibitory effects of kojic acid on melanin formation: In vitro and in vivo studies in black goldfish,]. Jap. Cosmet. Sci. Soc., 6, 193-194 (1982). (12) Y. Ohyama and Y. Mishima, Melanogenesis-inhibitory effect of kojic acid and its action mechanism, Fragrance, 18, 53-58 (1990). (13) J. T. Lim, Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid, Dermatol. Surg., 25, 282-284 (1999). (14) A. Garcia and J.E. Fulton, The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions, Dermatol. Surg., 22, 443--447 (1996). (15) E. V. Curto, C. Kwong, H. Hermersdorfer, et al., Inhibitors of mammalian melanocyte tyrosinase: In vitro comparisons of alkyl esters of gentistic acid with other putative inhibitors, Biochem. Pharmacol., 57, 663-672 (1999). (16) T. Sugai, Clinical effects of arbutin in patients with chloasma (in Japanese), Hifu (Skin Res.), 34, 522-529 (1992). (17) A. K. Chakraborty, Y. Funasaka, M. Komoto, and M. Ichihashi, Effect of arbutin on melanogenic proteins in human melanocytes, Pigment Cell Res., 11, 206-212 (1998). (18) K. Maeda and M. Fukuda, Arbutin: Mechanism of its depigmenting action in human melanocyte culture,]. Pharmacol. Exp. Therapeutics, 276, 765-769 (1996). (19) M. Nakajima, I. Shinoda, Y. Fukuwatari, and H. Hayasawa, Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity, Pigment Cell Res., 11, 12-17 (1998). (20) H. Matsuda, S. Nakamura, H. Shiomoto, T. Tanak, and M. Kubo, Pharmacological studies on leaf of Arctostaphylos uva-ursi (1.) Spreng. IV. Effect of SO% methanolic extract from Arctostaphylos uva-ursi (1.) Spreng (bearberry leaf) on melanin synthesis. (inJapanese), Yakugaku-Zasshi.J 112, 276-282 (1992). (21) R. E. Boissy and P. Manga, On the etiology of contact/occupational vitiligo, Pigment Cell Res., 17, 208-214 (2004). (22) H. Zhao and R. E. Boissy, Distinguishing between the catalytic potential and apparent expression of tyrosinase activities, Am.]. Med. Sci., 308, 322-330 (1994). (23) S. Pomerantz, Tyrosine hydroxylation catalyzed by mammalian tyrosinase: An improved method of assay, Biochem. Biophys. Res. Commun., 16, 188-194 (1964.) (24) S. E. Papadakis, S. Abdul-Malek, R. E. Kamdem, and K. L. Yam, A versatile and inexpensive tech­ nique for measuring color of foods, Food Technology, 54, 48-51 (2000). (25) S. Passi, M. Picardo, and M. Nazzaro-Porro, Comparative cytotoxicity of phenols in vitro, Biochemj., 245, 537-542 (1987). (26) C. J. Smith, K. B. O'Hare, and J.C. Allen, Selective cytotoxicity of hydroquinone for melanocyte­ derived cells is mediated by tyrosinase activity but independent of melanin content, Pigment Cell Res., 1, 386-389 (1988). (27) N. Watanabe and H.J. Forman, Autoxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in AS49-S cells, Arch. Biochem. Biophys., 411, 145-157 (2003). (28) M. P. Tabibian, Skin lightening/depigmenting agents, eMedicine ]., 2, 1-7 (2001). (29) K. Jimbow, H. Obata, M.A. Pathak, and T. B. Fitzpatrick, Mechanism of depigmentation by hyd­ roquinone,J. Invest. Dermatol., 62, 436-449 (1974). (30) G. A. Gellin and H. I. Maibach, Chemically induced depigmentation, Models Dermatol., 2, 282-286 (1985). (31) K-1. Nihei and I. Kubo, Identification of oxidation product of arbutin in mushroom tyrosinase assay system, Bioorgan. Medicin. Chem. Lett., 13, 2409-2412 (2003). (32) B. Kasraee, Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis­ inhibiting effects of chemical agents (editorial), Dermatology., 205, 329-339 (2002).

308 JOURNAL OF COSMETIC SCIENCE (33) H.B. Dunford and A. J. Adeniran, Hammet rho sigma correlation for reactions of horseradish per­ oxidases compound II with phenols, Arch. Biochem. Biophys., 251, 536-542 (1986). (34) D. C. Thompson, Y. N. Cha, and M.A. Trush, The peroxidases-dependent activation of butylated hydroxyanisole and butylated hydroxyroluene (BHT) to reactive intermediates: Formation of BHT­ quinone methide via a chemical-chemical interaction,]. Biol. Chem., 264, 3957-3965 (1989). (35) V. V. Subrahmanyam, P. Kolachana, and M. T. Smith, Metabolism of hydroquinone by human my­ eloperoxidase: Mechanisms of stimulation by other phenolic compounds, Arch. Biochem. Biophys., 286, 76-84 (1991). (36) J.J. Yohn, D. A. Norris, D. G. Yrastorza, I.J. Buno,J. A. Leff, S.S. Hake, and]. E. Repine, Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes and melanocytes, ]. Invest. Dermatol., 97, 405--409 (1991). (37) J. Z. Farooqui, B. W. Auclair, E. Robb, E. Sarkisian, C. Cooper, J. W. Alexander, G. Warden, R. E. Boissy, and J. J. Nordlund, Histological, biochemical, and ultrastructural studies on hyperpigmented human skin xenografts, Pigment Cell Res., 6, 226-233 (1993). (38) R. J. Mann and R. R. M. Harman, Nail staining due to hydroquinone skin-lightening creams, Br.]. Dermatol., 108, 363-365 (1983). (39) I. H. Coulson, "Fade out" photochromonychia, Clin. Exper. Dermatol., 18, 87-88 (1993). (40) R. L. Garcia, J. W. White, and W. F. Willis, Hydroquinone nail pigmentation, Arch. Dermatol, 114, 1402-1403 (1978).